Last reviewed · How we verify
Lanthanum Polystyrene Sulphonate Powder — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Lanthanum Polystyrene Sulphonate Powder (Lanthanum Polystyrene Sulphonate Powder) — Grand Life Science (Liaoning) Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lanthanum Polystyrene Sulphonate Powder TARGET | Lanthanum Polystyrene Sulphonate Powder | Grand Life Science (Liaoning) Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lanthanum Polystyrene Sulphonate Powder CI watch — RSS
- Lanthanum Polystyrene Sulphonate Powder CI watch — Atom
- Lanthanum Polystyrene Sulphonate Powder CI watch — JSON
- Lanthanum Polystyrene Sulphonate Powder alone — RSS
Cite this brief
Drug Landscape (2026). Lanthanum Polystyrene Sulphonate Powder — Competitive Intelligence Brief. https://druglandscape.com/ci/lanthanum-polystyrene-sulphonate-powder. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab